May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Optic Neuropathy and Alpha–1 Antitrypsin Deficiency
Author Affiliations & Notes
  • J.R. Younger
    Ophthalmology, UT Southwestern, Dallas, TX
  • J.G. McHenry
    Ophthalmology, UT Southwestern, Dallas, TX
  • R.N. Hogan
    Ophthalmology, UT Southwestern, Dallas, TX
  • F.R. Jones
    Ophthalmology, UT Southwestern, Dallas, TX
  • Footnotes
    Commercial Relationships  J.R. Younger, None; J.G. McHenry, None; R.N. Hogan, None; F.R. Jones, None.
  • Footnotes
    Support  Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 732. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.R. Younger, J.G. McHenry, R.N. Hogan, F.R. Jones; Optic Neuropathy and Alpha–1 Antitrypsin Deficiency . Invest. Ophthalmol. Vis. Sci. 2006;47(13):732.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : We describe several patients with optic neuropathy who also have alpha–1 antitrypsin(AAT) deficiency.

Methods: : A small series of patients with optic neuropathy at a University Ophthalmology clinic and their laboratory results of serum protein electrophoresis(SPEP) and serum AAT were recorded.

Results: : Eight patients (3 male, 5 female) aged 10–66 years (mean = 46.2 years) with optic neuropathy and AAT deficiency were identified. Their other carried diagnoses included idiopathic(n=6), thiamine deficiency(n=1) and pseudotumor cerebri(n=1). Visual acuity ranged from 20/25 to hand motion. All patients presented with varying degrees of bilateral optic pallor. Visual field defects were noted in seven of 8 patients. All patients were found to have low alpha–1 fraction(alpha–1 globulin) on SPEP ranging from 0.04g/dL to 0.13g/dL (average = 0.10g/dL) (normal = 0.14–0.26g/dL). Subsequent serum AAT levels ranged from 67mg/dL to 129mg/dL (average = 107mg/dL) (normal = 125–418mg/dL). No patients were known to have lung disease or other clotting abnormalities.

Conclusions: : Although optic neuropathy is recognized to be associated with coagulation disorders, to our knowledge the association with AAT has not been described. In this small series of patients with varied presentations, low levels of alpha–1 fraction and AAT were found. AAT is a serine protease inhibitor involved in the coagulation cascade including the protein C pathway, in which abnormalities are associated with hypercoaguable states. Low levels of serum AAT may have a role in ischemia leading to optic neuropathy. We report these cases to demonstrate the need to test for AAT deficiency in patients with clinical manifestations of optic neuropathy as it is clearly underdiagnosed.

Keywords: neuro-ophthalmology: optic nerve • optic disc • visual fields 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.